You are here

  • Home
  • Archive
  • Volume 18, Issue 1
  • Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications

Article info

Article menu
Download PDFPDF
Therapeutics
Systematic review
Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications

Authors

  1. Correspondence to: Dr Maria T DeSancho
    1305 York Avenue, 7th floor, New York, NY 10021, USA; mtd2002{at}med.cornell.edu
View Full Text

Citation

DeSancho MT, Pastores SM
Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications
BMJ Evidence-Based Medicine 2013;18:28-29.

Publication history

  • First published June 27, 2012.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions